Antibiotics and pregnancy

Pharmazie

Volumn 60, Issue 7, 2005, Pages 483-493

  Sá Del Fiol, Fernando ^a,c   Gerenutti, M ^a   Groppo, F C ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SOROCABA   (Brazil)

^c NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZITHROMYCIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLARITHROMYCIN; ERTAPENEM; ERYTHROMYCIN; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LINEZOLID; MACROLIDE; MEROPENEM; METRONIDAZOLE; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN; STREPTOMYCIN; SULFONAMIDE; TEICOPLANIN; TELITHROMYCIN; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC THERAPY; ATAXIA; BACTERIAL CELL WALL; BACTERIAL INFECTION; BACTERIAL METABOLISM; BONE MARROW TOXICITY; CARDIOVASCULAR MALFORMATION; CLEFT PALATE; DIARRHEA; DIZZINESS; DNA SYNTHESIS INHIBITION; DRUG CLASSIFICATION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG SAFETY; EOSINOPHILIA; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; GRAY BABY SYNDROME; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INJECTION SITE REACTION; KERNICTERUS; LIVER TOXICITY; NAUSEA; NEPHROTOXICITY; NEUROMUSCULAR BLOCKING; NEUROTOXICITY; NONHUMAN; OPPORTUNISTIC INFECTION; OTOTOXICITY; PERINATAL INFECTION; PLACENTAL TRANSFER; PNEUMOCYSTIS PNEUMONIA; PREGNANCY; PROTEIN SYNTHESIS INHIBITION; RASH; RED MAN SYNDROME; RESPIRATORY TRACT INFECTION; REVIEW; SEPSIS; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; STEVENS JOHNSON SYNDROME; SYNDROME DELINEATION; TASTE DISORDER; TONGUE DISEASE; TOOTH DISEASE; URINARY TRACT INFECTION; URINARY TRACT MALFORMATION;

ADULT; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; NUCLEIC ACID SYNTHESIS INHIBITORS; PREGNANCY; PROTEIN SYNTHESIS INHIBITORS;

EID: 22744447771     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Ahlfors CE (2000) Unbound bilirubin associated with kernicterus: a historical approach. J Pediatr 137: 540-544.
2. Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, Yood MU, Morse AN, Platt R (2004) Prescription drug use in pregnancy. Am J Obstet Gynecol 191: 398-407.
3. Aselton P, Jick H, Milunsky A, Hunter JR, Stergachis A (1985) First-trimester drug use and congenital disorders. Obstet Gynecol 65: 451-455.
4. Aventis Pharmaceutical Inc. Ketek - Telithromycin. Food and Drug Adm. 2004 - http://www.fda.gov/cder/foi/label/2004/21144_ketek_lbl.pdf searched May, 2004.
5. Aventis Pharmaceutical Inc. Rulide - Approved product information 2000 - http://www.pharma.aventis.com.au/corporate/products/pi/Rulide%20and %20Rulide%20D.pdf searched December, 2004.
6. Beard CM, Noller KL, O'Fallon WM, Kurland LT, Dahlin DC (1988) Cancer after exposure to metronidazole. Mayo Clin Proc 63: 147-153.
7. Berkovitch M, Pastuszak A, Gazarian M, Lewis M, Koren G (1994) Safety of the new quinolones in pregnancy. Obstet Gynecol 84: 535-538.
8. Bibler MR, Frame PT, Hagler DN, Bode RB, Staneck JL, et al. (1987) Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections. Antimicrob Agents Chemother 31: 207-212.
9. Birkenfeld A, Anteby SO. (1983) The effect of ampicillin and colistin on post-Caesarean section endometritis with identification of possible risk factors. Aust N Z J Obstet Gynaecol 23: 204-207.
10. Blanchard M, Oppliger R, Bucher U (1989) Positive direct Coombs' test in acute leukemias and other hemoblastoses: relation to clavulanic acid-containing antibiotics? Schweiz Med Wschr 14: 119: 39-45.
11. Boobis AR, Lewis P (1982) Drugs in pregnancy. Altered pharmacokinetics. Br J Hosp Med 28: 566-573.
12. th ed. Baltimore: Williams & Wilkins, p. 284-312.
13. R: Food and Drug Administration (2004) http://www.fda.gov/cder/foi/label/2002/50580slr033lbl.pdf searched May 2004.
14. Bryskier A (2000) Ketolides-telithromycin, an example of a new class of antibacterial agents. Clin Microbiol Infect 6: 661-669.
15. Bush MR, Rosa C (1994) Azithromycin and erythromycin in the treatment of cervical chlamydial infection during pregnancy. Obstet Gynecol 84: 61-63.
16. Campoli-Richards DM, Brogden RN, Faulds D (1990) Teicoplanin - A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 40: 449-486.
17. th ed., McGraw-Hill, p. 1239-1272.
18. Chan KW, Ng WL (1985) Gentamicin nephropathy in a neonate. Pathology 17: 514-515.
19. Chastre J, Brun P, Fourtillan, JB, Soler P, Basset G, Manuel C, Trouillet JL, Gibert C (1987) Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic. Antimicrob Agents Chemother 31: 1312-1315.
20. Chimura T, Morisaki N, Funayama T, Matsuo M (1990) Clinical studies on aztreonam in perinatal use. Jpn J Antibiot 43: 696-699.
21. Christensen B (2000) Which antibiotics are appropriate for treating bacteriuria in pregnancy? J Antimicrob Chemother 46 Suppl 1: 29-34.
22. Clark P (1992) Aztreonam. Obstet Gynecol Clin North Am 19: 519-528.
23. Clemett D, Markham A (2000) Linezolid. Drugs 59: 815-827.
24. Conway N, Birt BD (1965) Streptomycin in pregnancy: Effect on the foetal ear. Br Med J 31: 260-263.
25. Czeizel AE, Rockenbauer M (2000) A population-based case-control teratologic study of oral oxytetracycline treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 88: 27-33.
26. Czeizel AE, Rockenbauer M, Olsen J (1998) Use of antibiotics during pregnancy. Eur J Obstet Gynecol Reprod Biol 81: 1-8.
27. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J (1999a) Teratogenic evaluation of oxacillin. Scand J Infect Dis 31: 311-312.
28. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J (1999b) A population-based case-control teratologic study of oral erythromycin treatment during pregnancy. Reprod Toxicol 13: 531-536.
29. Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT (2000a) A teratological study of aminoglycoside antibiotic treatment during pregnancy. Scand J Infect Dis 32: 309-313.
30. Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT (2000b) Oral phenoxymethylpenicillin treatment during pregnancy. Results of a population-based Hungarian case-control study. Arch Gynecol Obstet 263: 178-181.
31. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J (2000c) A population-based case-control teratologic study of oral chloramphenicol treatment during pregnancy. Eur J Epidemiol 16: 323-327.
32. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J (2001a) The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. Reprod Toxicol 15: 637-646.
33. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J (2001b) Use of cephalosporins during pregnancy and in the presence of congenital abnormalities: a population-based, case-control study. Am J Obstet Gynecol 184: 1289-1296.
34. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J (2001c) A population-based case-control teratologic study of ampicillin treatment during pregnancy. Am J Obstet Gynecol 185: 140-147.
35. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J (2001d) Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: a population-based case-control teratologic study. Eur J Obstet Gynecol Reprod Biol 97: 188-192.
36. Danisovicova A, Brezina M, Belan S, Kayserova H, Kaiserova E, Hruskovic I, Orosova K, Dluholucky S, Galova K, Matheova E, et al. (1994) Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. A multicenter survey. Chemotherapy 40: 209-214.
37. rd (1997) Antibiotic use in pregnancy. Obstet Gynecol Clin North Am 24: 617-629.
38. Davey PG, Williams AH (1991) A review of the safety profile of teicoplanin. Antimicrob Chemother 27 Suppl B: 69-73.
39. Dencker BB, Larsen H, Jensen ES, Schonheyder HC, Nielsen GL, Sorensen HT (2002) Birth outcome of 1886 pregnancies after exposure to phenoxymethylpenicillin in utero. Clin Microbiol Infect 8: 196-201.
40. Dinsmoor MJ, Gibbs RS (1988) The role of the newer antimicrobial agents in obstetrics and gynecology. Clin Obstet Gynecol 31: 423-434.
41. Donald PR, Sellars SL (1981) Streptomycin ototoxicity in the unborn child. S Afr Med J 22: 316-318.
42. Douthwaite S, Hansen LH, Mauvais P (2000) Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA. Mol Microbiol 36: 183-193.
43. Egen-Lappe V, Hasford J (2004) Drug prescription in pregnancy: analysis of a large statutory sickness fund population. Eur J Clin Pharmacol 60: 659-666.
44. Einarson A, Phillips E, Mawji F, D'Alimonte D, Schick B, Addis A, Mastroiacova P, Mazzone T, Matsui D, Koren G (1998) A prospective controlled multicentre study of clarithromycin in pregnancy. Am J Perinatol 15: 523-525.
45. Einarson A, Shuhaiber S, Koren G (2001) Effects of antibacterials on the unborn child: what is known and how should this influence prescribing. Paediatr Drugs 3: 803-816.
46. Fonseca MRCC, Fonseca E, Bergsten-Mendes G (2002) Prevalence of drug use during pregnancy: a pharmacopepidemiological approach. Rev Saude Publica 36: 205-212.
47. R Abbott Laboratories (2000) http://www.fda.gov/cder/foi/label/2000/50662S29lbl.pdf, searched May 2004.
48. R FDA Label Information (2002) http:// www.fda.gov/cder/foi/label/2002/50717SLR004_Monurol_lbl.pdf, searched December 2004.
49. Garland SM, O'Reilly MA (1995) The risks and benefitis of antimicrobial therapy in pregnancy. Drug Saf 13: 188-205.
50. Gomes KR, Moron AF, Silva R, Siqueira AA (1999) Prevalence of use of medicines during pregnancy and its relationship to maternal factors. Rev Saude Publica 33: 246-254.
51. Grady R (2003) Safety profile of quinolone antibiotics in the pediatric population. Pediatr Infect Dis J 22: 1128-1132
52. rd ed., Oxford University Press 9: 32-48.
53. Hautekeete ML (1995) Hepatotoxicity of antibiotics. Acta Gastroenterol Belg 58: 290-296.
54. Hedstrom S, Martens MG (1993) Antibiotics in pregnancy. Clin Obstet Gynecol 36: 886-892.
55. Heikkila A, Erkkola R (1994) Review of beta-lactam antibiotics in pregnancy. The need for adjustment of dosage schedules. Clin Pharmacokinet 27: 49-62.
56. Heikkila A, Renkonen OV, Erkkola R (1992) Pharmacokinetics and transplacental passage of imipenem during pregnancy. Antimicrob Agents Chemother 36: 2652-2655.
57. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA (2000) Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 30: 1608-1614.
58. Honein MA, Paulozzi LJ, Himelright IM, Lee B, Cragan JD, Patterson L, Correa A, Hall S, Erickson JD (1999) Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: a case review and cohort study. Lancet 354: 2101-2105.
59. Hooton TM, Stamm WE (1997) Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 11: 551-581.
60. Jacobson GF, Autry AM, Kirby RS, Liverman EM, Motley RU (2001) A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. Am J Obstet Gynecol 184: 1352-1354.
61. Jamjian C, Biedenbach DJ, Jones RN (1997) In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004. Antimicrob Agents Chemother 41: 454-459.
62. Jepsen P, Skriver MV, Floyd A, Lipworth L, Schonheyder HC, Sorensen HT (2003) A population-based study of maternal use of amoxicillin and pregnancy outcome in Denmark. Br J Clin Pharmacol 55: 216-221.
63. Johnson TN (2003) The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children. Toxicology 192: 37-48.
64. Knight M (1994) Adverse drug reactions in neonates. J Clin Pharmacol 34: 128-135.
65. Knothe H, Dette GA (1985) Antibiotics in pregnancy: toxicity and teratogenicity. Infection 13: 49-51.
66. Larsen B, Glover DD (1998) Serum erythromycin levels in pregnancy. Clin Ther 20: 971-977.
67. Larsen H, Nielsen GL, Sorensen HT, Moller M, Olsen J, Schonheyder HC (2000) A follow-up study of birth outcome in users of pivampicillin during pregnancy. Acta Obstet Gynecol Scand 79: 379-383.
68. Lewis JH (2000) Drug-induced liver disease. Med Clin North Am 84: 1275-1311.
69. Loebstein R, Addis A, Ho E, Andreou R, Sage S, Donnenfeld AE, Schick B, Bonati M, Moretti M, Lalkin A, Pastuszak A, Koren G (1998) Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob Agents Chemother 42: 1336-1339.
70. Loebstein R, Koren G (2002) Clinical relevance of therapeutic drug monitoring during pregnancy. Ther Drug Monit 24: 15-22.
71. Loebstein R, Lalkin A, Koren G (1997) Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 33: 328-343.
72. Louik C, Werler MM, Mitchell AA (2002) Erythromycin use during pregnancy in relation to pyloric stenosis. Am J Obstet Gynecol 186: 288-290.
73. Mantovani A, Calamandrei G (2001) Delayed developmental effects following prenatal exposure to drugs. Curr Pharm Des 7: 859-880.
74. Marynowski A, Sianozecka E (1972) Comparison of the incidence of congenital malformations in neonates from healthy mothers and from patients treated because of tuberculosis. Ginekol Pol 43: 713-715.
75. Matsuda S, Suzuki M, Oh K, Ishikawa M, Soma A, Takada H, Shimizu T, Makinoda S, Fujimoto S, Chimura T, et al. (1988) Pharmacokinetic and clinical studies on imipenem/cilastatin sodium in the perinatal period. A study of imipenem/cilastatin sodium in the perinatal co-research group. Jpn J Antibiot 41: 1731-1741.
76. Mengue SS, Schenkel EP, Duncan BB, Schmidt MI (2001) Drug use by pregnant women in six Brazilian cities. Rev Saude Publica 35: 415-420.
77. Mensa J, García-Vázquez E, Vila J (2003) Macrólidos, cetólidos y estreptograminas. Enferm Infecc Microbiolo Cin 21: 200-208.
78. Merck & Co. Inc (2004) Invanz - Food and Drug Administration www.fda. gov/medwatch/SAFETY/2004/apr_PI/Invanz_PI.pdf searched December, 2004.
79. Murphy JF (1984) Drugs and pregnancy. Ir Med J 77: 52-56.
80. Nagai A, Miyazaki M, Morita T, Furubo S, Kizawa K, Fukumoto H, Sanzen T, Hayakawa H, Kawamura Y (2002) Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs. J Toxicol Sci 27: 219-228.
81. Niebyl JR (2003) Antibiotics and other anti-infective agents in pregnancy and lactation. Am J Perinatol 20: 405-414.
82. Ortiz-Ruiz G, Vetter N, Isaacs R, Carides A, Woods GL, et al. (2004) Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-bind studies. J Antimicrob Chemother 53: 59-66.
83. R M Parenteral. Food and Drug Administration (1997) http://www.fda.gov/cder/ogd/rld/50108s21.pdf, searched December, 2004.
84. Patel SS, Balfour JA, Bryson HM (1997) Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs 53: 637-656.
85. Perkins RP (1971) Hydrops fetalis and stillbirth in a male glucose-6-phosphate dehydrogenase-deficient fetus possibly due to maternal ingestion of sulfisoxazole; a case report. Am J Obstet Gynecol 111: 379-381.
86. R. Food and Drug Administration (2003) http://www.fda.gov/cder/foi/label/2004/50670slr021,50693slr008,50730slr 011_zithromax_lbl.pdf, searched May, 2004.
87. R Label Information (2004) http:// www.fda.gov/cder/foi/label/2004/21130se5-006,21131se5-007,21132se 5-006_zyvox_lbl.pdf, searched December, 2004.
88. Philipson A, Sabath LD, Charles D (1973) Transplacental passage of erythromycin and clindamycin. N Engl J Med 288: 1219-1221.
89. Philipson A, Stiernstedt G, Ehrnebo M (1987) Comparison of the pharmacokinetics of cephradine and cefazolin in pregnant and non-pregnant women. Clin Pharmacokinet 12: 136-144.
90. Piper JM, Mitchel EF, Ray WA (1993) Prenatal use of metronidazole and birth defects: no association. Obstet Gynecol 82: 348-352.
91. Preston SL (2004) The importance of appropriate antimicrobial dosing: pharmacokinetic and pharmacodynamic considerations. Ann Pharmacother 38: S14-8.
92. Rastogi N, Goh KS, Ruiz P, Casal M (1995) In vitro activity of roxithromycin against the Mycobacterium tuberculosis complex. Antimicrob Agents Chemother 39: 1162-1165.
93. Reid DW, Caille G, Kaufmann NR (1975) Maternal and transplacental kinetics of trimethoprim and sulfamethoxazole, separately and in combination. Can Med Assoc J 112: 67-72.
94. Rodin P, Hass G (1966) Metronidazole and pregnancy. Br J Vener Dis 42: 210-212.
95. Sá Del Fiol F, Rocha De Mattos Filho T, Groppo FC (2000) Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains. Braz J Infect Dis. 4: 36-42.
96. Saravanos K, Duff P (1992) The quinolone antibiotics. Obstet Gynecol Clin North Am 19: 529-537.
97. Schonwald S, Kuzman I, Oreskovic K, Burek V, Skerk V, Car V, Bozinovic D, Culig J, Radosevic S (1999) Azithromycin: single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome - a randomized study. Infection 27: 198-202.
98. Shepherd GM (2003) Hypersensitivity reactions to drugs: evaluation and management. Mt Sinai J Med 70: 113-125.
99. Sorensen HT, Larsen H, Jensen ES, Thulstrup AM, Schonheyder HC, Nielsen GL, Czeizel A (1999) Safety of metronidazole during pregnancy: a cohort study of risk of congenital abnormalities, preterm delivery and low birth weight in 124 women. J Antimicrob Chemother 44: 854-856.
100. Sorensen HT, Skriver MV, Pedersen L, Larsen H, Ebbesen F, Schonheyder HC (2003) Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Scand J Infect Dis 35: 104-106.
101. Stein GE (1998) Single-dose treatment of acute cystitis with fosfomycin tromethamine. Ann Pharmacother 32: 215-219.
102. Swaney SM, Aoki H, Ganoza MC, Shinabarger DL (1998) The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother 42: 3251-3255.
103. Teppler H, Gesser RM, Friedland IR, Woods GL, Meibohm A, et al. (2004) Safety and tolerability of ertapenem. J Antimicrob Chemother 53: 75-81.
104. The Medical Letter Consultants (1987) Safety of antimicrobial drugs in pregnancy. Med Let Drugs Ther 29: 61-63
105. Weinstein AJ, Gibbs RS, Gallagher M (1976) Placental transfer of clindamycin and gentamicin in term pregnancy. Am J Obstet Gynecol 124: 688-691.
106. Weller TMA, Rees EN (2000) Antibacterial use in pregnancy. Drug Saf 22: 335-338.
107. Williams ME, Thomas D, Harman CP, Mintz PD, Donowitz GR (1985) Positive direct antiglobulin tests due to clavulanic acid. Antimicrob Agents Chemother 27: 125-127.
108. Yabe K, Yoshida K, Yamamoto N, Nishida S, Ohshima C, Sekiguchi M, Yamada K, Furuhama K (1997) Diagnosis of quinolone-induced arthropathy in juvenile dogs by use of magnetic resonance (MR) imaging. J Vet Med Sci 59: 597-599.